Tuberculosis: clinical trials and new drug regimens.


PURPOSE OF REVIEW Recent advances in the development of new drugs and regimens provide hope that well tolerated, effective, and shorter-duration treatments for tuberculosis (TB) will become available. This review covers the recent trials of new TB drugs and regimens. RECENT FINDINGS Moxifloxacin and levofloxacin have equally good efficacy and safety in… (More)
DOI: 10.1097/MCP.0000000000000045



Citations per Year

Citation Velocity: 20

Averaging 20 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.